108 related articles for article (PubMed ID: 27161678)
1. OC-06 - Pro-thrombotic biomarkers in pancreatic diseases: are they specific of cancer?
Faille D; Ajzenberg N; de Chaisemartin L; Granger V; Chollet-Martin S; de Raucourt E; Hammel P; Lévy P; Ruszniewski P; Rebours V
Thromb Res; 2016 Apr; 140 Suppl 1():S170-1. PubMed ID: 27161678
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for the risk of thrombosis in pancreatic adenocarcinoma are related to cancer process.
Faille D; Bourrienne MC; de Raucourt E; de Chaisemartin L; Granger V; Lacroix R; Panicot-Dubois L; Hammel P; Lévy P; Ruszniewski P; Ajzenberg N; Rebours V
Oncotarget; 2018 May; 9(41):26453-26465. PubMed ID: 29899870
[TBL] [Abstract][Full Text] [Related]
3. Coagulation activation and microparticle-associated coagulant activity in cancer patients. An exploratory prospective study.
van Doormaal F; Kleinjan A; Berckmans RJ; Mackman N; Manly D; Kamphuisen PW; Richel DJ; Büller HR; Sturk A; Nieuwland R
Thromb Haemost; 2012 Jul; 108(1):160-5. PubMed ID: 22535219
[TBL] [Abstract][Full Text] [Related]
4. Impact of breast cancer stage, time from diagnosis and chemotherapy on plasma and cellular biomarkers of hypercoagulability.
Chaari M; Ayadi I; Rousseau A; Lefkou E; Van Dreden P; Sidibe F; Ketatni H; Galea V; Khaterchi A; Bouzguenda R; Frikha M; Ghorbal L; Daoud J; Kallel C; Quinn M; Gligorov J; Lotz JP; Hatmi M; Elalamy I; Gerotziafas GT
BMC Cancer; 2014 Dec; 14():991. PubMed ID: 25535397
[TBL] [Abstract][Full Text] [Related]
5. OC-04 - Tissue factor positive microvesicles activate platelets in vitro and in vivo and enhance thrombosis in mice.
Hisada Y; Geddings JE; Boulaftali Y; Getz TM; Whelihan M; Fuentes R; Dee R; Cooley BC; Key NS; Wolberg AS; Bergmeier W; Mackman N
Thromb Res; 2016 Apr; 140 Suppl 1():S169-70. PubMed ID: 27161676
[TBL] [Abstract][Full Text] [Related]
6. Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features.
Thaler J; Ay C; Mackman N; Metz-Schimmerl S; Stift J; Kaider A; Müllauer L; Gnant M; Scheithauer W; Pabinger I
Eur J Clin Invest; 2013 Mar; 43(3):277-85. PubMed ID: 23398637
[TBL] [Abstract][Full Text] [Related]
7. Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers.
Bharthuar A; Khorana AA; Hutson A; Wang JG; Key NS; Mackman N; Iyer RV
Thromb Res; 2013 Aug; 132(2):180-4. PubMed ID: 23856554
[TBL] [Abstract][Full Text] [Related]
8. Tissue factor pathway inhibitor on circulating microparticles in acute myocardial infarction.
Steppich B; Mattisek C; Sobczyk D; Kastrati A; Schömig A; Ott I
Thromb Haemost; 2005 Jan; 93(1):35-9. PubMed ID: 15630488
[TBL] [Abstract][Full Text] [Related]
9. Microparticle-associated tissue factor activity and venous thrombosis in multiple myeloma.
Auwerda JJ; Yuana Y; Osanto S; de Maat MP; Sonneveld P; Bertina RM; Leebeek FW
Thromb Haemost; 2011 Jan; 105(1):14-20. PubMed ID: 21057704
[TBL] [Abstract][Full Text] [Related]
10. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer.
Haubold K; Rink M; Spath B; Friedrich M; Chun FK; Marx G; Amirkhosravi A; Francis JL; Bokemeyer C; Eifrig B; Langer F
Thromb Haemost; 2009 Jun; 101(6):1147-55. PubMed ID: 19492160
[TBL] [Abstract][Full Text] [Related]
11. Tumour expresion of tissue factor and tissue factor pathway inhibitor in ovarian cancer- relationship with venous thrombosis risk.
Abu Saadeh F; Norris L; O'Toole S; Mohamed BM; Langhe R; O'Leary J; Gleeson N
Thromb Res; 2013 Nov; 132(5):627-34. PubMed ID: 24094893
[TBL] [Abstract][Full Text] [Related]
12. Elevated tissue factor and tissue factor pathway inhibitor circulating levels in ischaemic heart disease patients.
Falciani M; Gori AM; Fedi S; Chiarugi L; Simonetti I; Dabizzi RP; Prisco D; Pepe G; Abbate R; Gensini GF; Neri Serneri GG
Thromb Haemost; 1998 Mar; 79(3):495-9. PubMed ID: 9531029
[TBL] [Abstract][Full Text] [Related]
13. PO-27 - Thrombin generation in pancreatic cancer and multiple myeloma with use of calibrated automated thrombography.
Adesanya MA; Maraveyas A; Madden LA
Thromb Res; 2016 Apr; 140 Suppl 1():S186. PubMed ID: 27161715
[TBL] [Abstract][Full Text] [Related]
14. Microparticle-associated tissue factor activity in patients with metastatic pancreatic cancer and its effect on fibrin clot formation.
Thaler J; Koder S; Kornek G; Pabinger I; Ay C
Transl Res; 2014 Feb; 163(2):145-50. PubMed ID: 23973167
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for venous thromboembolism in cancer: novel findings from the Vienna Cancer and Thrombosis Study (CATS).
Königsbrügge O; Pabinger I; Ay C
Thromb Res; 2014 May; 133 Suppl 2():S39-43. PubMed ID: 24862144
[TBL] [Abstract][Full Text] [Related]
16. Procoagulant activity of extracellular vesicles as a potential biomarker for risk of thrombosis and DIC in patients with acute leukaemia.
Gheldof D; Haguet H; Dogné JM; Bouvy C; Graux C; George F; Sonet A; Chatelain C; Chatelain B; Mullier F
J Thromb Thrombolysis; 2017 Feb; 43(2):224-232. PubMed ID: 28074413
[TBL] [Abstract][Full Text] [Related]
17. Microparticle-associated tissue factor activity, venous thromboembolism and mortality in pancreatic, gastric, colorectal and brain cancer patients.
Thaler J; Ay C; Mackman N; Bertina RM; Kaider A; Marosi C; Key NS; Barcel DA; Scheithauer W; Kornek G; Zielinski C; Pabinger I
J Thromb Haemost; 2012 Jul; 10(7):1363-70. PubMed ID: 22520016
[TBL] [Abstract][Full Text] [Related]
18. Impaired control of the tissue factor pathway of blood coagulation in systemic lupus erythematosus.
Adams MJ; Palatinus AA; Harvey AM; Khalafallah AA
Lupus; 2011 Dec; 20(14):1474-83. PubMed ID: 21993387
[TBL] [Abstract][Full Text] [Related]
19. Procoagulant tissue factor activity on microparticles is associated with disease severity and bacteremia in febrile urinary tract infections.
Woei-A-Jin FJ; van der Starre WE; Tesselaar ME; Garcia Rodriguez P; van Nieuwkoop C; Bertina RM; van Dissel JT; Osanto S
Thromb Res; 2014 May; 133(5):799-803. PubMed ID: 24657035
[TBL] [Abstract][Full Text] [Related]
20. Tissue factor over-expression by human pancreatic cancer cells BXPC3 is related to higher prothrombotic potential as compared to breast cancer cells MCF7.
Gerotziafas GT; Galea V; Mbemba E; Khaterchi A; Sassi M; Baccouche H; Prengel C; van Dreden P; Hatmi M; Bernaudin JF; Elalamy I
Thromb Res; 2012 Jun; 129(6):779-86. PubMed ID: 21917301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]